Breast cancer in African-American women: differences in tumor biology from European-American women.

Disparities exist between African-American and European-American women in the incidence and nature of breast cancer. African-American women are more often diagnosed with breast cancer at an earlier age and with more aggressive disease, characterized by higher grade and negative estrogen and progesterone receptor status. Recent findings reveal specific gene expression patterns associated with the more aggressive breast cancers observed in African-American women. An overview of the current literature about racial differences in breast cancer prompts questions for future research to elucidate causes for the apparent disparities in tumor biology.

[1]  D. Miglioretti,et al.  Does Utilization of Screening Mammography Explain Racial and Ethnic Differences in Breast Cancer? , 2006, Annals of Internal Medicine.

[2]  C. Perou,et al.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.

[3]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[4]  L. Newman,et al.  Breast cancer in sub‐Saharan Africa: How does it relate to breast cancer in African‐American women? , 2005, Cancer.

[5]  J. Cunningham,et al.  Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis , 2004, Breast Cancer Research and Treatment.

[6]  L. Newman Breast carcinoma in African‐American and White women , 2004, Cancer.

[7]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[8]  C. Perou,et al.  Race and the poor prognosis basal breast tumor (BBT) phenotype in the population-based Carolina Breast Cancer Study (CBCS). , 2004, Journal of Clinical Oncology.

[9]  R. Coates,et al.  Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma , 2004, Cancer.

[10]  William D. Foulkes,et al.  Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .

[11]  S. Joslyn Hormone Receptors in Breast Cancer: Racial Differences in Distribution and Survival , 2002, Breast Cancer Research and Treatment.

[12]  R. Millikan,et al.  Tumor characteristics in African American and white women , 2001, Breast Cancer Research and Treatment.

[13]  J. Cunningham,et al.  Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis , 2004, Breast Cancer Research and Treatment.

[14]  L. Bégin,et al.  Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. , 2004, Journal of the National Cancer Institute.

[15]  A. Ellis Breast , 2002, BMJ : British Medical Journal.

[16]  Philip M. Long,et al.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Malone,et al.  Differences in breast cancer stage, treatment, and survival by race and ethnicity. , 2003, Archives of internal medicine.

[19]  J. Baselga,et al.  HER-Targeted Tyrosine-Kinase Inhibitors , 2002, Oncology.

[20]  J. Baselga Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  B. Hankey,et al.  Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. , 2002, American journal of epidemiology.

[22]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[23]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[25]  C. C. Johnson,et al.  Race and differences in breast cancer survival in a managed care population. , 1999, Journal of the National Cancer Institute.

[26]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[27]  S. Gapstur,et al.  Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases , 1996, Cancer.

[28]  G M Clark,et al.  Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. , 1994, Journal of the National Cancer Institute.

[29]  C. Redmond,et al.  Histological characteristics of breast carcinoma in blacks and whites. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  C. Osborne,et al.  Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[32]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[33]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.